Transcription of ZEPOSIA U.S. Prescribing Information
{{id}} {{{paragraph}}}
Example: marketing
ZEPOSIA U.S. Prescribing Information
HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use ZEPOSIA safely and effectively. See full Prescribing Information for (ozanimod) capsules, for oral useInitial Approval: 2020------------------------------RECENT MAJOR CHANGES------------------------------Ind ications and Usage (1) 5/2021 Dosage and Administration ( , ) 12/2021 Warnings and Precautions ( , , , , , , ) 12/2021------------------------------IND ICATIONS AND USAGE ------------------------------ ZEPOSIA is a sphingosine 1-phosphate receptor modulator indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020-----RECENT MAJOR CHANGES-----
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: